Occlutech Overview
- Founded
- 2003
- Status
- Private
- Employees
- 290
- Latest Deal Type
- IPO
- (Cancelled)
- Financing Rounds
- 4
- Investments
- 2
Occlutech General Information
Description
Occlutech Holding AG is a provider of minimally invasive structural heart disease devices. It develops, manufactures, and commercializes structural heart and interatrial shunt products to improve the treatment of patients. Occlutech markets and sells its structural heart and interatrial shunt products to hospitals and clinics in over 80 countries through its direct sales organization and international network of distribution partners.
Contact Information
Website
www.occlutech.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Feldstrasse 22
- 8200 Schaffhausen
- Switzerland
Occlutech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Occlutech‘s full profile, request access.
Request a free trialOcclutech Patents
Occlutech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3741312-A1 | Occluder with stretchable waist | Withdrawn | 22-May-2019 | 000000000000 | 00 |
| EP-3552556-A1 | Vascular implant with anchor member | Withdrawn | 11-Apr-2018 | 00000000000 | 0 |
| CA-3126178-A1 | Vascular implant with anchor member | Pending | 11-Apr-2018 | 00000000000 | |
| EP-3799559-A1 | Vascular implant with anchor member | Pending | 11-Apr-2018 | 00000000000 | |
| US-10595999-B2 | Flow regulating device in the heart | Active | 09-Sep-2014 | A61F2/2493 | 0 |
Occlutech Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Sabine Bois | Chief Executive Officer | ||
| Lars Wadell | Chief Financial Officer | ||
| Marianne Alexandersson | Chairman & Board Member |
Occlutech Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000000 | Self | Board Member | 000 0000 |
| 00000000 0000000000000 | Self | Chairman & Board Member | 000 0000 |
| 00000-00000 000000 | Self | Board Member | 000 0000 |
| 000000 0000000 | Self | Board Member | 000 0000 |
| 000 000000 | Self | Board Member | 000 0000 |
Occlutech Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOcclutech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Occlutech‘s full profile, request access.
Request a free trialOcclutech Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000000 | 21-May-2021 | 00000 0000 | 00.000 | Educational and Training Services (B2C) | |
| NonWoTecc | 12-Jan-2013 | Merger/Acquisition | Therapeutic Devices | 000 00000 |